Latest Breaking News On - Company at the market - Page 1 : comparemela.com

Bionomics : SECURITIES PURCHASE AGREEMENT - Form 6-K

SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT is made and entered into as of May 31, 2024 by and among Bionomics Limited, a public company incorporated under.

United statesNew yorkNew york stock exchangeCommonwealth of australiaSpyros papapetropoulosTheodorej ghorraNeither the companyGood laboratory practiceGroup incCompany counselInternational accounting standards boardCompany the first closing subscription amountLeerink partnersCompany constitutionFinancial action task force on money launderingAgreements of the company

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMatt crensonIan karpAlina liJohn leonardCompany progressEuropean commissionHealth care conferenceEuropean medicines agencyRegeneron pharmaceuticals incCompany at the marketExchange commissionCorporate communicationsRecode therapeutics incVivo program updates

Quantum Computing Inc Reports Third Quarter and Nine Months 2023 Financial Results

Quantum Computing Inc Reports Third Quarter and Nine Months 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomNew york universityNew yorkJames simon jrJavad shabaniQci diracRobert liscouskiBrian lamacchiaQuantum computing incCalifornia nanosystems instituteTrustees of the stevens institute technologyEntropy quantum computersCyber protection ltd recyberScience technology directorate

Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

FDA cleared NTLA-2001 IND application for first in vivo CRISPR candidate to enter late-stage clinical development; on track to initiate the MAGNIT.

United kingdomCity ofIan karpJohn leonardAlina liMatt crensonCorporate communicationsIntellia therapeutics incExchange commissionRegeneron pharmaceuticals incVivo program updatesCompany at the marketDrug administrationEuropean medicines agencyClinical trial applicationIntellia president

Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomJohn leonardBill chaseLina liseniorVivo program updatesDrug administrationCompany at the marketExchange commissionCorporate communicationsRegeneron pharmaceuticals incEuropean academy of allergyIntellia therapeutics incClinical trial applicationIntellia president